Ollin Biosciences launches with $100M Series A to develop breakthrough vision therapies—Excedr covers this major biotech funding round announcement.
What types of lab equipment are needed to support AI-driven drug discovery? Learn how to scale smartly with flexible, cost-effective procurement strategies.
Alchemab Therapeutics pioneers resilience-based drug discovery—Excedr covers this major biotech funding round.
How can accelerators better support life science startups? Leasing lab equipment offers a flexible way to equip labs without heavy upfront costs.
Compare phase contrast vs. fluorescence microscopy. Learn use cases, key differences, and how to choose the right technique for imaging live cells.
Learn how leasing equipment supports flexible, cost-effective biomanufacturing expansion for biotechs and life sciences companies scaling production.
Learn how diagnostic labs can use equipment leasing to reduce upfront costs, modernize workflows, and scale efficiently with the latest medical technology.
NRG Therapeutics secures major funding to target Neurodegeneration—Excedr covers the latest funding news.
LB Pharmaceuticals’ $285M IPO fuels schizophrenia drug LB-102—Excedr covers this major biotech funding round.
Learn about lab infrastructure mistakes that can stall funding—and how to build operational credibility that attracts grants and investors.
